organisation
BOARD OF DIRECTORS
PRESIDENT
Dr. Steffen Denzinger
Director Business Development Actives & Formulation –
Merck Life Science KGaA
VICE-PRESIDENT
Dr. Gildas Barreyre
Energy and Public Affairs Director –
SEQENS
Ms. Ana Marti
General Counsel, IP & RA –
Mr. Enrico Allievi
Director- Aschimfarma Federchimica
Mr. Gian Mario Baccalini
Curia Global
Dr. Christine Chartroux
Head of Sales & New Business development – WeylChem
Chair of the FAME Committee
Mr. David Demailly
API Commercial Director – Aspen Oss B.V.
Ms. Mila Jové
General Manager – Afaquim
Dr. Martin Jochen Klatt
Vice-President – BASF SE
Ms. Céline Crusson-Rubio
Managing Director – SICOS
Mr. Matt Moran
Director – BioPharmaChem Ireland
Dr. Gian Paolo Negrisoli
President and CEO – Flamma Group
Dr. Roberta Pizzocaro
President Olon Group
Dr. Jürgen Roos
Chief Scientific Officer – Siegfried Holding AG
Dr. Vincent Touraille
Head of Strategy – EuroAPI – Sanofi Chimie
MANAGER
Mrs. Maggie Saykali
Director, Specialty Chemicals – Cefic